Zhiyi Zhang
No. 321 Zhongshan Road
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Antiviral treatment response to nucleos(t)ide analogues in chronic hepatitis B patients with normal alanine aminotransferase levels: a retrospective multi-center study.
Journal: Emerging microbes & infections
Published: November 12, 2025
Hidden weaknesses and biological insights in machine learning models of fibrosis in autoimmune hepatitis-authors' reply.
Journal: QJM : monthly journal of the Association of Physicians
Published: October 07, 2025
Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment.
Journal: Emerging microbes & infections
Published: September 17, 2025
Antiviral Therapy Reduces Hepatocellular Carcinoma and Cirrhosis Risk in Chinese Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 29, 2025
Extreme gradient boosting-based explainable machine learning model for predicting significant fibrosis in autoimmune hepatitis.
Journal: QJM : monthly journal of the Association of Physicians
Published: April 06, 2025
Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B.
Journal: Virulence
Published: September 24, 2024
Optimization of the Use of APRI and FIB-4 for Ruling Out Liver Cirrhosis in Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
Journal: Journal of viral hepatitis
Published: August 26, 2024
Clinical Features and Transition of Acute Hepatitis B Virus Infection.
Journal: Journal of viral hepatitis
Published: June 03, 2024
Favourable Prognosis of Patients With Untreated HBeAg-Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mL.
Journal: Alimentary pharmacology & therapeutics
Published: May 25, 2024
Clinical utility of the treatment eligibility score HEPSANET for chronic hepatitis B in Asia.
Journal: The Lancet regional health. Western Pacific
Published: April 16, 2024
Last Updated: 09/26/2026